RxDoctor Payments Data

Raymond Taetle

Hematology & Oncology · Tucson, AZNPI 1326002411

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,425 of the $8,406 with a category attached, or 64.5%. 27 manufacturers reported payments, led by Ipsen Biopharmaceuticals, Inc at 50.7% of the total. That places this record below the midpoint for hematology & oncology clinicians in AZ, where the typical reported total is $6,870.

$8,406in general payments, 2019–2025

Across 173 payments — averaging $48.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$4K
  • Bristol Myers Squibb$2K
  • Amgen$368
  • E.r. Squibb & Sons, L.L.C.$250
  • Merck$199
  • Pfizer$197
  • plus $964 from 21 others
$36,176in research payments, 2019–2025

Across 2 payments — averaging $18,088 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$36K

What the payments were for

  • Consulting fees$5,42565%
  • Travel & lodging$7719%
  • Food & beverage$2,21026%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,406 in reported general payments places this provider in the 50th percentile of 261 hematology & oncology providers in Arizona.

See all hematology & oncology providers in Arizona →

Other hematology & oncology in Tucson

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →